Tissue distribution and activity studies of 1,24-dihydroxyvitamin D 2, a metabolite of vitamin D 2 with low calcemic activity in vivo

Biochemical Pharmacology

Volumn 68, Issue 7, 2004, Pages 1289-1296

  Brown, Alex J ^a   Ritter, Cynthia S ^a   Holliday, L Shannon ^a   Knutson, Joyce C ^b   Strugnell, Stephen A ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Bone Care International   (United States)

Author keywords

1,24 Dihydroxyvitamin D 2; Calcium; Intestine; Metabolism; Osteoclast; Vitamin D

Indexed keywords

1,24 DIHYDROXYVITAMIN D 2; CALCITRIOL; ERGOCALCIFEROL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BONE MARROW; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL MATURATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG POTENCY; DUODENUM; ISOTOPE LABELING; KIDNEY; MALE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; CALCIUM; ERGOCALCIFEROLS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 4444262839     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.06.015     Document Type: Article

References (37)

1. A.J. Brown, A.S. Dusso, and E. Slatopolsky Vitamin D analogues for secondary hyperparathyroidism Nephrol. Dial. Transplant. 17 Suppl 10 2002 10 19
2. H.M. Maung, L. Elangovan, J.M. Frazao, J.D. Bower, B.J. Kelley, and S.R. Acchiardo Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison Am. J. Kidney Dis. 37 2001 532 543
3. K. Fogh, and K. Kragballe Recent developments in Vitamin D analogs Curr. Pharm. Des. 6 2000 961 972
4. J.A. Kanis, E.V. McCloskey, D. de Takats, J. Bernard, and D.M. Zhang Treatment of osteoporosis with Vitamin D Osteoporos. Int. 7 1997 s140 s146
5. K.W. Colston, S.K. Chander, A.G. Mackay, and R.C. Coombes Effects of synthetic Vitamin D analogues on breast cancer cell proliferation in vivo and in vitro Biochem. Pharmacol. 44 1992 693 702
6. S.S. Jensen, M.W. Madsen, J. Lukas, J. Bartek, and L. Binderup Sensitivity to growth suppression by 1alpha,25-dihydroxyvitamin D-3 among MCF-7 clones correlates with Vitamin D receptor protein induction J. Steroid Biochem. Mol. Biol. 81 2 2002 123 133
7. 2 Prostate 55 2003 159 167
8. 3 analog EB1089 Endocrinology 139 1998 2102 2110
9. 2 in a retinoblastoma xenograft model Arch. Ophthalmol. 120 5 2002 607 612
10. 3 analogs to inhibit growth of prostate cancer cells in vivo Anticancer Res. 23 2003 283 289
11. J.L. Osborn, G.G. Schwartz, D.C. Smith, R. Bahnson, R. Day, and D.L. Trump Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer Urol. Oncol. 1 1995 195 198
12. D.C. Smith, C.S. Johnson, C.C. Freeman, J. Muindi, J.W. Wilson, and D.L. Trump A phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy Clin. Cancer Res. 5 1999 1339 1345
13. 2 in normal and immortalized human epidermal cells Biochem. Pharmacol. 52 1996 133 140
14. 2, calcitriol, and calcipotriol Biochem. Pharmacol. 53 1997 829 837
15. 2 detectable in human serum J. Clin. Endocrinol. Metab. 83 1998 2156 2166
16. 2 in mammals Biochemistry 29 1990 578 582
17. 2 made in the human hepatoma, Hep3B Biochem. J. 310 1995 233 241
18. 3 in growth regulation of cancer cell lines Anticancer Res. 18 1998 1769 1776
19. A.J. Brown, J. Finch, F. Takahashi, and E. Slatopolsky Calcemic activity of 19-nor-1,25(OH)(2)D(2) decreases with duration of treatment J. Am. Soc. Nephrol. 11 2000 2088 2094
20. L.S. Holliday, S.L. Gluck, E. Slatopolsky, and A.J. Brown 1,25-Dihydroxy-19-nor-Vitamin D(2), a Vitamin D analog with reduced bone resorbing activity in vitro J. Am. Soc. Nephrol. 11 2000 1857 1864
21. 2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal Vitamin D receptor content Am. J. Kidney Dis. 30 1997 105 112
22. L.L. Issa, G.M. Leong, R.L. Sutherland, and J.A. Eisman Vitamin D analogue-specific recruitment of Vitamin D receptor coactivators J. Bone Miner. Res. 17 5 2002 879 890
23. 3 on intestinal calcium and phosphate transport J. Lab. Clin. Med. 139 5 2002 279 284
24. M. Hirata, K. Katsumata, K. Endo, N. Fukushima, H. Ohkawa, and M. Fukagawa In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)(2) Vitamin D(3) Nephrol. Dial. Transplant. 18 2003 1770 1776
25. A.J. Brown, J. Finch, M. Gridff, C. Ritter, N. Kubodera, and Y. Nishii The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine Endocrinology 133 1993 1158 1164
26. 3 J. Bone Miner. Res. 7 1992 835 839
27. N. Takahashi, H. Yamana, S. Yoshiki, G.D. Roodman, G.R. Mundy, and S.J. Jones Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures Endocrinology 122 1988 1373 1382
28. N. Takahashi, H. Yamana, S. Yoshiki, G.D. Roodman, G.R. Mundy, and S.J. Jones Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures Endocrinology 122 1988 1373 1382
29. 3-24-hydroxylase, a multicatalytic enzyme Biochemistry 35 1996 8465 8472
30. T. Sakaki, N. Sawada, Y. Nonaka, Y. Ohyama, and K. Inouye Metabolic studies using recombinant Escherichia coli cells producing rat mitochondrial CYP24 - CYP24 can convert 1alpha,25-dihydroxyvitamin D-3 to calcitroic acid Eur. J. Biochem. 262 1 1999 43 48
31. 3 in rat kidney but not in intestine J. Biol. Chem. 267 1992 13757 13762
32. S.X. Wu, S.Y. Ren, H. Chen, R.F. Chun, M.A. Gacad, and J.S. Adams Intracellular Vitamin D binding proteins: novel facilitators of Vitamin D-directed transactivation Mol. Endocrinol. 14 9 2000 1387 1397
33. G. Jones, S.A. Strugnell, and H.F. DeLuca Current understanding of the molecular actions of Vitamin D Physiol. Rev. 78 1998 1193 1231
34. J.T. Mortensen, P. Brinck, and L. Binderup Toxicity of Vitamin D analogues in rats fed diets with standard or low calcium contents Pharmacol. Toxicol. 72 1993 124 127
35. 3 J. Nutr. Sci. Vitaminol. 35 1989 529 533
36. 3, in rats J. Biochem. (Tokyo) 115 1994 373 380
37. R. Horst, S. Prapong, T. Reinhardt, N. Koszewski, J. Knutson, and C. Bishop Comparison of the relative effects of 1,24-dihydroxyvitamin D(2) [1,24-(OH)(2)D(2)], 1,24-dihydroxyvitamin D(3) [1,24-(OH)(2)D(3)], and 1,25-dihydroxyvitamin D(3) [1,25-(OH)(2)D(3)] on selected Vitamin D-regulated events in the rat Biochem. Pharmacol. 60 2000 701 708